CIK: 0001595851 · Show all filings
Period: Q1 2017 (← Previous) (Next →)
Filing Date: May 15, 2017
Total Value: $537M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SERIES TRUST | 900,000 | $62.41M | 11.6% | — | — | Put | 78464A870 |
| IWM | ISHARES TR | 250,000 | $34.37M | 6.4% | — | — | Put | 464287655 |
| SPY | SPDR S&P 500 ETF TR | 100,000 | $23.57M | 4.4% | — | — | Put | 78462F103 |
| — | DBV TECHNOLOGIES S A | 500,000 | $17.61M | 3.3% | $35.76 | — | SPONSORED ADR | 23306J101 |
| — | AVEXIS INC | 175,000 | $13.3M | 2.5% | $46.75 | — | COM | 05366U100 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 300,000 | $12.99M | 2.4% | $42.84 | 0.0% | COM | 64125C109 |
| — | CLOVIS ONCOLOGY INC | 200,000 | $12.73M | 2.4% | $16.16 | — | COM | 189464100 |
| BCRX | BIOCRYST PHARMACEUTICALS | 1,500,000 | $12.6M | 2.3% | $4.04 | +72.1% | COM | 09058V103 |
| — | SEATTLE GENETICS INC | 200,000 | $12.57M | 2.3% | $55.30 | — | COM | 812578102 |
| ZBH | ZIMMER BIOMET HLDGS INC | 100,000 | $12.21M | 2.3% | $113.85 | -7.4% | COM | 98956P102 |
| ACAD | ACADIA PHARMACEUTICALS INC | 350,000 | $12.03M | 2.2% | $34.90 | +1.1% | COM | 004225108 |
| BSX | BOSTON SCIENTIFIC CORP | 450,000 | $11.19M | 2.1% | $19.09 | +27.4% | COM | 101137107 |
| — | SPARK THERAPEUTICS INC | 200,000 | $10.67M | 2.0% | $51.96 | — | COM | 84652J103 |
| — | ACCELERON PHARMA INC | 400,000 | $10.59M | 2.0% | $26.38 | — | COM | 00434H108 |
| — | EPIZYME INC | 600,000 | $10.29M | 1.9% | $13.15 | — | COM | 29428V104 |
| — | AERIE PHARMACEUTICALS INC | 220,000 | $9.977M | 1.9% | $37.77 | — | Call | 00771V108 |
| VRTX | VERTEX PHARMACEUTICALS INC | 90,000 | $9.842M | 1.8% | $88.04 | 0.0% | COM | 92532F100 |
| — | IMMUNOMEDICS INC | 1,500,000 | $9.705M | 1.8% | $2.79 | — | COM | 452907108 |
| MRK | MERCK & CO INC | 150,000 | $9.531M | 1.8% | $44.08 | +4.5% | COM | 58933Y105 |
| — | SPECTRANETICS CORP | 325,000 | $9.464M | 1.8% | $15.14 | — | Call | 84760C107 |
| — | ENDOLOGIX INC | 1,300,000 | $9.412M | 1.8% | $7.24 | — | COM | 29266S106 |
| ENTA | ENANTA PHARMACEUTICALS INC | 300,000 | $9.24M | 1.7% | $31.14 | 0.0% | COM | 29251M106 |
| — | NUVASIVE INC | 120,000 | $8.962M | 1.7% | $57.34 | — | COM | 670704105 |
| — | LION BIOTECHNOLOGIES INC | 1,200,000 | $8.94M | 1.7% | $7.22 | — | COM | 53619R102 |
| — | ADURO BIOTECH INC | 800,000 | $8.6M | 1.6% | $10.75 | — | COM | 00739L101 |
| PBYI | PUMA BIOTECHNOLOGY INC | 225,000 | $8.37M | 1.6% | $36.49 | 0.0% | COM | 74587V107 |
| — | GENMARK DIAGNOSTICS INC | 650,000 | $8.333M | 1.6% | $12.82 | — | COM | 372309104 |
| BMY | BRISTOL MYERS SQUIBB CO | 150,000 | $8.157M | 1.5% | $39.53 | +1.0% | Call | 110122108 |
| — | NANOSTRING TECHNOLOGIES INC | 400,000 | $7.948M | 1.5% | $17.11 | — | COM | 63009R109 |
| — | PORTOLA PHARMACEUTICALS INC | 200,000 | $7.838M | 1.5% | $39.19 | — | COM | 737010108 |
| — | TESARO INC | 50,000 | $7.694M | 1.4% | $84.06 | — | Call | 881569107 |
| AGIO | AGIOS PHARMACEUTICALS INC | 125,000 | $7.3M | 1.4% | $52.47 | -8.6% | COM | 00847X104 |
| ACAD | ACADIA PHARMACEUTICALS INC | 207,200 | $7.124M | 1.3% | $34.90 | +1.1% | Put | 004225108 |
| — | SAGE THERAPEUTICS INC | 100,000 | $7.107M | 1.3% | $46.68 | — | COM | 78667J108 |
| — | NOVADAQ TECHNOLOGIES INC | 900,000 | $7.011M | 1.3% | $7.79 | — | COM | 66987G102 |
| — | RA PHARMACEUTICALS INC | 300,000 | $6.387M | 1.2% | $19.76 | — | COM | 74933V108 |
| — | ACORDA THERAPEUTICS INC | 300,000 | $6.3M | 1.2% | $21.30 | — | COM | 00484M106 |
| — | K2M GROUP HLDGS INC | 285,000 | $5.845M | 1.1% | $20.51 | — | COM | 48273J107 |
| — | WRIGHT MED GROUP N V | 185,000 | $5.757M | 1.1% | $22.80 | — | ORD SHS 0.03 PAR | N96617118 |
| PRTA | PROTHENA CORP PLC | 100,000 | $5.579M | 1.0% | $52.54 | 0.0% | SHS | G72800108 |
| — | NXSTAGE MEDICAL INC | 200,000 | $5.366M | 1.0% | $26.83 | — | COM | 67072V103 |
| — | SHIRE PLC | 30,000 | $5.227M | 1.0% | $170.38 | — | SPONSORED ADR | 82481R106 |
| — | ENTELLUS MED INC | 375,000 | $5.175M | 1.0% | $16.60 | — | COM | 29363K105 |
| INCY | INCYTE CORP | 35,000 | $4.678M | 0.9% | $116.27 | +9.5% | COM | 45337C102 |
| — | SPECTRANETICS CORP | 155,000 | $4.514M | 0.8% | $15.14 | — | COM | 84760C107 |
| — | BLUEPRINT MEDICINES CORP | 100,000 | $3.999M | 0.7% | $39.99 | — | COM | 09627Y109 |
| — | ZOGENIX INC | 365,000 | $3.96M | 0.7% | $11.21 | — | COM NEW | 98978L204 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 375,000 | $3.773M | 0.7% | $14.87 | 0.0% | COM | 19459J104 |
| — | AQUINOX PHARMACEUTICALS INC | 225,000 | $3.755M | 0.7% | $13.36 | — | COM | 03842B101 |
| — | RIGEL PHARMACEUTICALS INC | 1,100,000 | $3.641M | 0.7% | $2.62 | — | COM NEW | 766559603 |
| IRIX | IRIDEX CORP | 250,000 | $2.968M | 0.6% | $14.17 | -0.8% | COM | 462684101 |
| — | INTRA CELLULAR THERAPIES INC | 150,000 | $2.438M | 0.5% | $16.25 | — | COM | 46116X101 |
| — | DERMIRA INC | 65,000 | $2.217M | 0.4% | $34.11 | — | COM | 24983L104 |
| — | CYMABAY THERAPEUTICS INC | 500,000 | $2.15M | 0.4% | $4.30 | — | COM | 23257D103 |
| — | CONFORMIS INC | 400,000 | $2.088M | 0.4% | $5.22 | — | COM | 20717E101 |
| PTCT | PTC THERAPEUTICS INC | 200,000 | $1.968M | 0.4% | $12.10 | 0.0% | COM | 69366J200 |
| — | STEMLINE THERAPEUTICS INC | 225,000 | $1.924M | 0.4% | $8.55 | — | COM | 85858C107 |
| — | CURRENCYSHARES SWISS FRANC T | 19,300 | $1.835M | 0.3% | $93.73 | — | SWISS FRANC SH | 23129V109 |
| — | ZOSANO PHARMA CORP | 940,000 | $1.786M | 0.3% | $1.90 | — | COM | 98979H103 |
| — | MIRATI THERAPEUTICS INC | 172,184 | $895K | 0.2% | $13.43 | — | COM | 60468T105 |
| — | AVEO PHARMACEUTICALS INC | 1,500,000 | $885K | 0.2% | $0.59 | — | COM | 053588109 |
| — | FOAMIX PHARMACEUTICALS LTD | 125,000 | $619K | 0.1% | $10.31 | — | SHS | M46135105 |
| XENE | XENON PHARMACEUTICALS INC | 150,000 | $600K | 0.1% | $7.72 | +1.8% | COM | 98420N105 |
| — | AKARI THERAPEUTICS PLC | 46,622 | $516K | 0.1% | $18.60 | — | SPONSORED ADR | 00972G108 |